Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? NO.
Aaron
Shawn D
SD
The Ottawa Hospital, Ottawa, Ontario. saaron@ohri.ca
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents / Q000627:therapeutic use; D000075202:Contraindications; D004341:Drug Evaluation; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D016896:Treatment Outcome
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents